161 related articles for article (PubMed ID: 10719420)
1. [The medical treatment of advanced non-small-cell lung carcinoma (adv NSCLC). The correlation with multidimensional assessment].
Guidi F; Paggi P; Lo Nardo D; Gattafoni P; Consales D
Minerva Med; 1999; 90(7-8):210-3. PubMed ID: 10719420
[No Abstract] [Full Text] [Related]
2. A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (Stage IIIB/IV) non-small cell lung cancer.
Chen YM; Perng RP; Yang KY; Liu TW; Tsai CM; Ming-Liu J; Whang-Peng J
Chest; 2000 Jun; 117(6):1583-9. PubMed ID: 10858387
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: a phase II study.
Lilenbaum R; Cano R; Schwartz M; Siegel L; Lutzky J; Lewis M; Krill E; Barreras L; Davila E
Cancer; 2000 Feb; 88(3):557-62. PubMed ID: 10649247
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: a minnie pearl cancer research network phase II trial.
Hainsworth JD; Burris HA; Litchy S; Erland JB; Hon JK; Brierre JE; Greco FA
Cancer; 2000 Mar; 88(6):1353-8. PubMed ID: 10717616
[TBL] [Abstract][Full Text] [Related]
5. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
Herbst RS; Khuri FR; Lu C; Liu DD; Fossella FV; Glisson BS; Pisters KM; Shin DM; Papadimitrakopoulou VA; Kurie JM; Blumenschein G; Kies MS; Zinner R; Jung MS; Lu R; Lee JJ; Munden RF; Hong WK; Lee JS
Cancer; 2002 Jul; 95(2):340-53. PubMed ID: 12124835
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.
Greco FA; Gray JR; Thompson DS; Burris HA; Erland JB; Barton JH; Litchy S; Houston GA; Butts JA; Webb C; Scott C; Hainsworth JD
Cancer; 2002 Sep; 95(6):1279-85. PubMed ID: 12216096
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer.
Frasci G; Lorusso V; Panza N; Comella P; Nicolella G; Bianco A; De Cataldis G; Iannelli A; Bilancia D; Belli M; Massidda B; Piantedosi F; Comella G; De Lena M
J Clin Oncol; 2000 Jul; 18(13):2529-36. PubMed ID: 10893283
[TBL] [Abstract][Full Text] [Related]
8. [Maintenance chemotherapy in advanced NSCLC].
Krazkowski M
Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S16-8. PubMed ID: 16719150
[No Abstract] [Full Text] [Related]
9. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic strategies in advanced non-small cell bronchial cancers: platin-based combinations].
Fournel P
Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S42-7. PubMed ID: 12538935
[No Abstract] [Full Text] [Related]
11. [New data presented at ASCO 2002 concerning non-small cell bronchial cancers].
Morère JF
Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S5-10. PubMed ID: 12538925
[No Abstract] [Full Text] [Related]
12. [New therapeutic approaches in non-small-cell lung carcinoma (NSCLC), stages IV].
Mavroudis D
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S42-5. PubMed ID: 11924243
[No Abstract] [Full Text] [Related]
13. Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial.
Gridelli C; Cigolari S; Gallo C; Manzione L; Ianniello GP; Frontini L; Ferraù F; Robbiati SF; Adamo V; Gasparini G; Novello S; Perrone F;
Lung Cancer; 2001; 31(2-3):277-84. PubMed ID: 11165408
[TBL] [Abstract][Full Text] [Related]
14. Bi-weekly administration of gemcitabine plus vinorelbine in elderly patients with advanced non-small-cell lung cancer: multicenter phase II trial.
Araya T; Kasahara K; Kimura H; Shibata K; Kita T; Shirasaki H; Hara J; Yoshimi Y; Sone T; Oribe Y; Nobata K; Nishi K; Fujimura M; Nakao S;
Lung Cancer; 2007 Jun; 56(3):371-6. PubMed ID: 17300851
[TBL] [Abstract][Full Text] [Related]
15. [Phase III clinical trials concerning non-small-cell lung carcinoma (NSCLC) presented at the ASCO 2001].
Morere JF
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S37-41. PubMed ID: 11924242
[No Abstract] [Full Text] [Related]
16. [The dilemma of first-line chemotherapy in advanced non-small-cell lung cancer: are third-generation drugs all the same?].
Grossi F; de Marinis F; Frontini L; Gridelli C
Tumori; 2008; 94(3):5-14. PubMed ID: 18705422
[No Abstract] [Full Text] [Related]
17. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.
Gagel B; Piroth M; Pinkawa M; Reinartz P; Zimny M; Fischedik K; Stanzel S; Breuer C; Skobel E; Asadpour B; Schmachtenberg A; Buell U; Eble MJ
Strahlenther Onkol; 2006 May; 182(5):263-9. PubMed ID: 16673059
[TBL] [Abstract][Full Text] [Related]
18. Histology classification is not a predictor of clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine or gemcitabine combinations.
Trani L; Myerson J; Ashley S; Young K; Sheri A; Hubner R; Puglisi M; Popat S; O'Brien ME
Lung Cancer; 2010 Nov; 70(2):200-4. PubMed ID: 20227784
[TBL] [Abstract][Full Text] [Related]
19. Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.
Curran MP; Plosker GL
Drugs Aging; 2002; 19(9):695-721. PubMed ID: 12381238
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancer.
Esteban E; Fra J; Sala M; Carrasco J; Corral N; Vieitez JM; Estrada E; Palacio I; Buesa JM; Lacave AJ
Invest New Drugs; 2002 Aug; 20(3):317-26. PubMed ID: 12201494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
